Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.

Smoking and alcohol worsen hair transplant results.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

The treatment improved hair growth and quality with minimal side effects.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Online forums help understand men's concerns about baldness and show the need for better support that changes how baldness is viewed.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

RF-based therapies might help treat hair loss.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

A hair implant clinic in Bogotá is feasible and can offer affordable treatments for medium-income individuals.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

Various treatments exist for hair loss, but no definitive solution.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Tailored medication preparation and ongoing education are crucial for effective treatments.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Finasteride helps hair growth but may cause sexual side effects and depression.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

Reflectance confocal microscopy can tell apart white dots on the scalp as either sweat gland ducts or hair follicle openings.